Liwen Yang

Liwen Yang

Auto-generated profile, based on publicly available information

Liwen Yang

University Hospital and Medical Faculty of the Heinrich Heine University Duesseldorf, Department of Obstetrics and Gynecology, Düsseldorf, Deutschland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2022 in Cytometry Part A
Verified
Journal Article
Open access
LYLiwen Yang
Liwen Yang
MRMahdi Rivandi
Mahdi Rivandi
AFAndré Franken
André Franken
MHMaarten Hieltjes
Maarten Hieltjes
PZPieter Jan van der Zaag
Pieter Jan van der Zaag
HNHans Neubauer
Hans Neubauer
Cell loss during detection and isolation of circulating tumor cells (CTCs) is a challenge especially when label-free pre-enrichment technologies are used without the aid of magnetic particles. Although microfluidic systems can remove the majority of "contaminating" white blood cells (WBCs), their remaining numbers are still impeding single CTC isolation, thus making additional separation steps needed. This study aimed to develop a workflow from blood-to-single CTC for complex cell suspensions by testing two microwell formats. In the first step, different cell lines were used to compare the performances of Sievewell (TM) 370 K (TOK, Japan) and CellCelector (TM) Nanowell U25 (ALS Automated Lab Solutions, Germany) slides for cell labelling and single-cell micromanipulation. Confounding levels of auto-fluorescence inherent to different plastic materials used to cast the microwells, staining recovery rates, and cell isolation rates were determined. In the second step, three different blood preservation tubes were tested for RNA analysis. Lastly, the established workflow was applied to isolate CTCs from peripheral blood samples obtained from metastasized breast cancer (mBC) patients for single-cell DNA and RNA analysis. The detection of CTCs in Sievewell slides profit from better signal-to-noise ratios in the fluorescence channels mainly used for CTC detection. In addition, due to its design, Sievewell supports direct in situ CTC labelling, which minimizes cell loss and leads to single-cell recovery rates after staining of approx. 94%. Detection of PIK3CA mutations in single CTCs verified the applicability of the workflow for the analysis of genomic DNA of CTCs. Furthermore, combined with blood preservation up to 48 h at room temperature in LBguard tubes, panel RT-PCR transcript analysis was successful for single cell line cells and CTCs, respectively. The combined use of Sievewell microwell slides and CellCelector (TM) automated micromanipulation system improves single CTC detection, labelling and isolation from complex cell suspensions. This approach is especially valuable when samples of high cellular content are processed.

30 September 2022 in Geburtshilfe und Frauenheilkunde
Verified
Journal Article
Closed access
LYL Yang
L Yang
AFA Franken
A Franken
MRM Rivandi
M Rivandi
DND Niederacher
D Niederacher
TFTanja Fehm
Tanja Fehm
HNHans Neubauer
Hans Neubauer
Background Tumor cells that have undergone a mesenchymal-epithelial transition (EMT) show upregulated CD44 and downregulated EpCAM expression, which may lead to therapy resistance and metastatic tumor spread. We aim to develop an appropriate method to enrich CTCs in an EpCAM-independent fashion and to analyze the role of CTCs, which express different levels of EpCAM and CD44. Methods Spike-in experiments with MCF7 and MDA-MB-231 cells were performed and processed with the Parsortix system (ANGLE plc, UK), cells were then characterized by immunofluorescent staining on Sievewell slide (TOK Co. Ltd., Japan). Labelled cells were imaged and enumerated with the CellCelector (ALS GmbH, Germany) platform. In a small study, blood from 23 metastasized BC patients was analyzed, single CD44pos CTCs were selected and genomic DNA was amplified (Ampli1, Menarini, Italy). Targeted sequencing analysis for PIK3CA, AKT1, ERBB2, and ESR1 was performed (Franken, et al. 2020). Results In MCF7 cells, 4.5 µm cassette & 99mBar pressure reached 92% ± 8% recovery rate, while 4.5 µm cassette & 50mBar pressure achieved 76% ± 19% with MDA-MB-231 cells. From 23 patient samples, in total 47 CD44pos and 120 CD44low/neg CTCs were isolated from 9 patient samples. Amplified genomic DNA of 77.78% (21/27) CD44pos CTCs and 59.52%–25/42) CD44low/neg CTCs from 7 patients resulted in high quality. ERBB2 mutations were observed in 4 CD44pos and 8 CD44low/neg CTCs from 3 patients. Conclusion With this workflow, CD44pos CTCs – a CTC subpopulation associated with therapy resistance and metastatic tumor spread – can be detected and isolated to identify targets for therapies. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

10 June 2022 in Senologie - Zeitschrift für Mammadiagnostik und -therapie
Verified
Journal Article
Closed access
AFA. Franken
A. Franken
BJB. Jaeger
B. Jaeger
MRM. Rivandi
M. Rivandi
LYL. Yang
L. Yang
FMF. Meier-Stiegen
F. Meier-Stiegen
HNHans Neubauer
Hans Neubauer
Objective Targeted therapy has become the preferred approach to treat most cancers, including metastatic breast cancer. However, the predictive utility of the primary tumor is limited and obtaining serial biopsies of metastatic lesions is challenging. Therefore, using liquid biopsies, which can act as a dynamic diagnostic tool, is an appealing concept. Here, we performed a comparative mutation analysis of tissue biopsies and circulating tumor cells (CTCs) yielded from blood. Material & methods DNA from the most recent tissue biopsies available of 27 metastatic breast cancer patients was extracted. CTCs were enriched with the CellSearch system and were isolated by micromanipulation. Clinically relevant mutation in PIK3CA, ESR1, AKT1, and ERBB2 were identified by next generation sequencing. Results CTCs were detected in 18 samples and sequencing results were obtained for CTCs of 15 patients. CTC analysis failed in 3 cases due to DNA degradation and low quantity of the CTCs. Predictive mutations were detected in tissue of 10 patients. If CTC positive, similar mutations were found in CTCs in all cases. Moreover, in CTCs from 5 patients, further predictive mutations in PIK3CA, ESR1, or AKT1 were identified that could not be detected in tissue. Conclusion The analysis of CTCs offers the opportunity to detect predictive information that could not be gained from tissue biopsies but may be of clinical relevance. Therefore, liquid biopsies should be considered as a powerful tool that complements tissue analysis to optimize targeted therapy selection. Article published online: 21 June 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

15 May 2019
Verified
Journal Article
Closed access
FWFengbiao Weng
Fengbiao Weng
LZLifan Zhu
Lifan Zhu
LYLiwen Yang
Liwen Yang
Yong LiYong Li
Yong Li
Rong LiuRong Liu
Rong Liu
JZJianxin Zhou
Jianxin Zhou